TP53 and anaplastic oligodendroglioma: Historically, in anaplastic oligodendroglioma with intact 1p, mutations in TP53 were found to stratify outcomes, with median survival of 71 versus 16 months in patients with mutant versus wild-type TP53, respectively [12].